Clinical Study Report (CSR) Synopses

Lilly provides the ability to search for Clinical Study Report (CSR) Synopses for Phase 2, Phase 3, and Phase 4 clinical trials that initiated on or after 15 October 2002 and studied the effects of medicines that are approved for use in the United States (US) and European Union (EU).

Lilly is working to complete the transfer of these CSR Synopses from different sources and will continue to update the search with historical trials. Newly completed studies will be provided in a timely manner for approved medicines after the approval of an indication has occurred in the US and EU and the primary peer reviewed publication is available.

The information is not intended to replace the advice of your physician and is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Lilly products. If you have any questions regarding any information contained in this link, please consult with your physician.

Please use the search at the bottom of this page to find trials of interest. The search provides the ability to search on any individual or combination of the following fields:

  • Trial Title
  • Trial Phase
  • NCT Number (this is the unique trial identification number from ClinicalTrials.gov)
  • Medical indication studied by the trial.
  • Lilly Trial ID
  • Generic name of the compound studied. For reference, please see the table below to match the trade names to generic names.
Trade Name Generic Name
Adcirca ® Tadalafil
Alimta ® Pemetrexed
Cialis  ® Tadalafil
Cymbalta ® Duloxetine
Cyramza ® Ramucirumab
Effient ® Prasugrel
Evista ® Raloxifene
Forteo ® Teriparatide
Gemzar ® Gemcitabine
Humalog ® Human Insulin Lispro
Humatrope ® Somatropin
Humulin ® Human Insulin
Prozac ® Fluoxetine
Strattera ® Atomoxetine
Symbyax ® Olanzapine and Fluoxetine
Trulicity TM Dulaglutide
Yentreve ® Duloxetine
Zyprexa ® Olanzapine

Search for CSR Synopses:


 

 

Please enable your browser's JavaScript setting in order to access this site